HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hyun-Sung Lee Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lee, H.-S. Search for Related Content PubMed Articles by Lee, H.-S. Related Collections Pleura Related Article

---

Original Articles: General Thoracic

Invited Commentary

Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, 111 Jungbalsan-ro, Ilsandong-gu, Goyang, Gyeonggi 410-769, Korea

(Email: thoracic@ncc.re.kr).

The first 20% of the full text of this article appears below.

I read with interest the article by Yan and colleagues [1]. Therapy of malignant pleural mesothelioma (MPM) has included chemotherapy, gene therapy, hyperthermia, immunotherapy, photodynamic therapy, radiation therapy, surgery, and supportive care. The effect of these various therapies for MPM on patient outcomes has been difficult to assess. At this moment, no therapy has been adequately shown to have any proven benefit in the treatment of MPM. The combination of complete surgery, being decortication or extrapleural pneumonectomy, in combination with hemithorax radiotherapy seems promising only in . . . [Full Text of this Article]

Related Article

Prognostic Features of Long-term Survivors After Surgical Management of Malignant Pleural Mesothelioma

Tristan D. Yan, Michael Boyer, Mo Mo Tin, Junyang Sim, Catherine Kennedy, Jocelyn McLean, Paul G. Bannon, and Brian C. McCaughan
Ann. Thorac. Surg. 2009 87: 1552-1556. [Abstract] [Full Text] [PDF]